Cell Line and Membrane Market

The increase in the prevalence of cancer & chronic diseases, rise in geriatric population, and increase in number of vaccine production are the key factors that boost the market growth.

The Cell Line and Membrane Market size was valued at $4.5 billion in 2021, and is estimated to reach $10.6 billion by 2031, growing at a CAGR of 8.8% from 2022 to 2031.

Download Free Sample Report-

https://www.alliedmarketresearch.com/request-sample/14227

Rise in the prevalence of cancer and chronic diseases, increase in the geriatric population, growth in the adoption of regenerative medicines, a surge in investments in R&D by pharmaceutical and biotechnology companies, rise in development & demand for monoclonal antibodies, increase in production of vaccines, and technological innovations in cell lines and the membrane fuel the growth of the global cell line and membrane market. However, a strict regulatory framework coupled with the time-consuming process for the development of stable lines might hinder the market growth. On the other hand, low-income countries lacking access to basic healthcare and an increase in the risk of pandemic and communicable diseases present new opportunities in the market in the coming years.

Key findings of the study

By product, the media and reagents segment were the highest contributor to the market in 2021

By source, the mammalian cell line segment was the highest contributor to the market in 2021.

By type, the recombinant cell line segment was the highest contributor in 2021.

By end user, the biotechnology and pharmaceutical industries dominated the market in 2021 and is expected to continue this trend during the forecast period.

By Region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Impact of Covid-19 on Cell Line and Membrane Market-

The outbreak of the Covid-19 pandemic positively impacted the cell line and membrane market, due to the growing number of pet adoption during the lockdown and rise in the demand for animal health insurance.

Moreover, many initiatives taken by the government to reduce disease prevalence among animals led to the growth of cell Line and membrane market. Launch of advanced products for the treatment of animals with minimal side effects boosted the market growth.

Furthermore, a rise in research and development activities increased the approval of new devices, testing procedures and drugs, thus offering opportunities for the key players to develop advanced devices for the quick diagnosis and prevention from such diseases.

For Purchase Inquiry-

https://www.alliedmarketresearch.com/purchase-enquiry/14227

North America to garner the largest revenue by 2031

Based on region, North America was the largest market in 2021, accounting for around two-fifths of the global cell line and membrane market, and is likely to lead the trail throughout the forecast period. This is due to the increase in the healthcare expenditure, a rise in the prevalence of cancer, growing demand for cell line for the development of therapeutic monoclonal antibodies and novel antibodies, and the presence of major players in this region. However, Asia-Pacific is anticipated to manifest the fastest CAGR of 9.8% during the forecast period, due to the rise in prevalence of chronic diseases, an increase in the geriatric population and an emerging economy in the region.

Leading Market Players

Advanced Instruments LLC
AGC Biologics
Cytiva Lifesciences
Sartorius Cellgenix Gmbh
Premas Biotech
Selexis SA
Lonza
Samsung Biologics
PromoCell
Thermofisher Scientific Inc.
Imegenex IndiaPvt. Ltd.
ProBioGen

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.